Rapid Diagnostic Kits Market for Indian Ocean Region Countries (France, India, Australia, Indonesia, Singapore, Sri Lanka, Madagascar) by Product (Professional, OTC), Platform (Immunoassay, Molecular), Application (Infectious Diseases, Cardiac, Urinalysis

Rapid Diagnostic Kits Market for Indian Ocean Region Countries (France, India, Australia, Indonesia, Singapore, Sri Lanka, Madagascar) by Product (Professional, OTC), Platform (Immunoassay, Molecular), Application (Infectious Diseases, Cardiac, Urinalysis, Cholesterol), End User (Hospital, Diagnostic Lab) - Forecast to 2029

Rapid Diagnostic Kits Market for Indian Ocean Region Countries by Product (Professional, OTC), Platform (Immunoassay, Molecular), Application (Infectious Diseases, Cardiac, Urinalysis, Cholesterol), End User (Hospitals, Diagnostic Labs)—Forecast to 2029

The rapid diagnostics kits market for Indian Ocean region countries is expected to grow at a CAGR of 1.6% from 2022 to 2029 to reach $1.75 billion by 2029.

Following thorough secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities.

The growing demand for PoC diagnostics, the high prevalence of chronic diseases coupled with the increasing geriatric population, the growing prevalence of infectious diseases, the increasing need for rapid decision-making, and the outbreak of the COVID-19 pandemic are the key factors driving growth in the market. However, variance in test results is a restraining factor for the growth of this market. Additionally, the reluctance to change the existing diagnostic practices is a major challenge for market growth.

Based on product, in 2022, the professional kits segment is expected to account for the larger share of the rapid diagnostic kits market in Indian Ocean region countries. The large market share of this segment is attributed to increasing hospitalizations, the high prevalence of chronic diseases such as cancer and cardiac conditions, the advantages of rapid diagnostic kits over laboratory tests, including low cost and low turnaround time, and their gradual increase in the use.

Based on platform, in 2022, the immunoassays segment is expected to account for the largest share of the rapid diagnostic kits market in Indian Ocean region countries. The large market share of this segment is mainly attributed to the high prevalence of chronic and infectious diseases, technological innovations, and the advantages of rapid immunoassay tests, such as cost-effectiveness and at-home testing.

Based on application, in 2022, the infectious diseases testing segment is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries. The high prevalence and outbreaks of infectious diseases and the high adoption of self-testing kits for infectious diseases are primary factors supporting the large market share of this segment.

Based on end user, in 2022, the hospitals & clinics segment is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries. Factors attributing to this segment's growth include increasing hospitalizations due to various diseases, the increasing geriatric population, and increased healthcare access & expenditure.

An in-depth analysis of the geographical scenario of the rapid diagnostic kits market for Indian Ocean region countries provides detailed qualitative and quantitative insights about the major geographies (France, India, Australia, Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and Seychelles). France is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries in 2022, followed by India, Australia, Indonesia, and Singapore.

Key companies operating in the rapid diagnostic kits market for Indian Ocean region countries are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).

Scope of the Report

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Product

Professional Kits
OTC Kits

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Platform

Immunoassays
Molecular Detection
Other Rapid Diagnostic Platforms

(Note – Other rapid diagnostic platforms include coagulation tests, glucose monitoring systems, and other rapid diagnostic platforms)

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Application

Infectious Diseases Testing
Pregnancy And Fertility Testing
Cardiac Metabolism Testing
Cholesterol Testing
Tumor/Cancer Markers Testing
Blood Glucose Testing
Urinalysis
Hematology Testing
Other Tests

(Note - Other tests include drugs of abuse, fecal occult, and coagulation tests)

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by End User

Hospitals & Clinics
Diagnostic Laboratories
Home Care/Self-testing
Other End Users

(Note - Other end users include ambulatory care centers, nursing homes, and public places (airports, hotels, and workplaces)

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Geography

France
India
Australia
Indonesia
Singapore
Sri Lanka
Madagascar
Mauritius
Reunion
Mayotte
Seychelles
Comoros

Rapid Diagnostic Kits Market for Indian Ocean Region Countries - Report Summary

Report Metrics	Details
Years Considered	2020 - 2029
Base Year	2021
Forecast Period	2022-2029
Page Count	145
Units Referenced	Value (USD Million)
Segments/Key Topics	Market by Product, Market by Platform, Market by Application, Market by End User
Regions Covered	France, India, Australia, Indonesia, Singapore, Sri Lanka, Madagascar, Mauritius, Reunion, Mayotte, Seychelles, Comoros
Key Companies Mentioned	Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), ACON Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).

FAQs About the Report

What is the focus of the rapid diagnostics kits market for Indian Ocean region countries?

This report provides an analysis of the rapid diagnostic kits market in Indian Ocean region countries (France, India, Australia, Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and Seychelles), covering platforms such as immunoassays and molecular detection used for applications such as blood glucose testing, cardiac metabolism testing, infectious diseases testing, coagulation testing, pregnancy & fertility testing, fecal occult testing, hematology testing, tumor/cancer markers testing, drugs of abuse testing, cholesterol testing, and urinalysis. The rapid diagnostics kits covered in this report provide diagnostic results expeditiously (within 1 hour).

What is the value of revenue generated from the sale of rapid diagnostics kits in Indian Ocean region countries? At what rate their demand expected to grow for the next 5-7 years?

The rapid diagnostics kits market for Indian Ocean region countries is projected to reach $1.75 billion by 2029, at a CAGR of 1.6% during the forecast period.

Which product type is expected to show the fastest growth rate during the forecast period?

In terms of product, the OTC kits segment is expected to show the fastest growth rate in the forecast period. The growth of this segment can be attributed to the rising demand for at-home testing, growing awareness about self-testing among the general population, and the increasing prevalence of diseases that require rapid and effective testing.

Which platform segment is estimated to hold the major share of the market?

In terms of platform, the immunoassays segment is expected to account for the largest share of the rapid diagnostic kits market in Indian Ocean region countries in 2022. Immunoassays based diagnostic kits are widely used in hospitals, clinical laboratories, and home care for the qualitative and quantitative diagnosis and management of communicable and non-communicable diseases.

Which application segment is expected to show the fastest growth rate during the forecast period?

In terms of application, the tumor/cancer markers testing segment is expected to show the fastest growth rate during the forecast period. The burden of cancer is growing, exerting tremendous economic strain on countries. Nearly 70% of cancer deaths occur in low- and middle-income countries (source: WHO). The burden of cancer is large in India, Australia, Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and Seychelles, for example, in 2020 India reported 1,324,413 new cancer cases and this number is projected to reach 1,692,968 by 2030(source: GLOBOCAN). Furthermore, France reported 467,965 new cancer cases and this number is projected to reach 530,863 by 2030 (source: GLOBOCAN). Early detection is very important in reducing mortality, improving the chances of survival, and saving on treatment costs. Various rapid diagnostic kits are used to detect cancer. It is estimated that the demand for rapid diagnostic kits that support cancer testing will grow significantly in the coming years.

Which end user segment is estimated to hold the major share of the market?

In terms of end user, the hospitals & clinics segment is expected to account for the largest share of the rapid diagnostic kits market in Indian Ocean region countries in 2022. Factors attributing to this segment's growth include the rising number of hospitalizations due to various diseases, the increasing geriatric population, and rising healthcare access & expenditure.

What are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the rapid diagnostic kits market in Indian Ocean region countries?

The growth of this market is driven by the growing demand for PoC diagnostics, the high prevalence of chronic diseases coupled with the increasing geriatric population, the growing prevalence of infectious diseases, the increasing need for rapid decision-making, and the outbreak of the COVID-19 pandemic. Moreover, emerging countries are expected to offer growth opportunities for the players operating in the rapid diagnostic kits market in Indian Ocean region countries.

Who are the major players operating in the rapid diagnostic kits market in Indian Ocean region countries?

Some of the key companies operating in the rapid diagnostic kits market for Indian Ocean region countries are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), ACON Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).